Complicated Urinary Tract Infection
Infectious Disease
9 drugs in development·8 companies·2 clinical trials
Drug Pipeline by Phase
Approved(5)
Phase 3(1)
| Drug | Company |
|---|---|
| tebipenem hbr | Spero Therapeutics, Inc. (SPRO) |
Phase 1(1)
Preclinical(1)
| Drug | Company |
|---|---|
| nrx-101 | NRX Pharmaceuticals Inc. (NRXP) |
BLA Filed(1)
| Drug | Company |
|---|---|
| plazomicin | Achaogen, Inc. (AKAO) |
Compare drugs
Frequently asked questions
How many drugs are in development for Complicated Urinary Tract Infection?
BioSniper tracks 9 drugs in development for Complicated Urinary Tract Infection across 8 companies.
How many clinical trials target Complicated Urinary Tract Infection?
There are 2 clinical trials targeting Complicated Urinary Tract Infection tracked by BioSniper.
Deep-dive into Complicated Urinary Tract Infection
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis